Capstone Investment Advisors
NXTM

Capstone Investment Advisors’s NxStage Medical Inc. NXTM Stock Holding History

Capstone Investment Advisors’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-87,065
Closed -$2.49M – 1406
2018
Q4 		$2.49M Sell
87,065
-69,072
-44% -$1.96M 0.03% 394
2018
Q3 		$4.36M Sell
156,137
-58,537
-27% -$1.65M 0.05% 276
2018
Q2 		$5.99M Buy
214,674
+12,914
+6% +$346K 0.09% 140
2018
Q1 		$5.02M Buy
+201,760
New +$4.91M 0.1% 140

Other funds holding NXTM

TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

Capstone Investment Advisors's NXTM Position: Q1 2019 in Review

Capstone Investment Advisors sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 87,065 shares — an estimated $2.49M sold.

Capstone Investment Advisors first reported a position in NXTM in Q1 2018 and held it in 4 quarters. The position peaked at $5.99M in Q2 2018. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • Capstone Investment Advisors reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • Capstone Investment Advisors sold 87,065 NxStage Medical Inc. shares in Q1 2019, an estimated $2.49M.
  • Capstone Investment Advisors first reported a position in NxStage Medical Inc. in Q1 2018 and held it in 4 quarters.
  • Capstone Investment Advisors's NxStage Medical Inc. position peaked at $5.99M in Q2 2018.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on Capstone Investment Advisors's 13F filing for Q1 2019, filed 15 May 2019.